Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The annual National Institute for Health Research (NIHR) Oxford cognitive health Clinical Research Facility (CRF) Open Day, held Tuesday 19 May, was a great success, with patients, public, carers and various teams from across the Oxford Health NHS Foundation Trust and Oxford universities in attendance.

The CRF, which provides a wide range of clinical and scientific resources and patient facilities to enable high quality translational neuroscience studies, invited participants to a variety of talks, interactive sessions and poster presentations.

Mary-Jane Attenburrow, Senior Clinical Research Fellow and Clinical Lead CRF commented: “We were delighted to see so many people visit the CRF for International Clinical Trials Day. One of the presentations was given by a patient who gave a  very powerful, moving  and informative account of the experience of living with bipolar disorder, she has also been actively involved in many research studies.”

In addition, Professor John Geddes, Head of Department of Psychiatry (University of Oxford), Director of Research & Development (Oxford Health NHS Foundation Trust) said of the day:  “The success of the open day – and the increase in scale and attendance since last year - clearly demonstrates that Oxford Health NHS FT is now engaging with research very seriously and with a clear sense of purpose. Working with colleagues across the Academic Health Sciences Centre, NIHR nationally and internationally, I expect a further exponential growth over the forthcoming year – with delivery of real benefits for our patients.”

Links:

Clinical Research Facility (CRF)

Similar stories

Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age

A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.

Drug could help diabetic hearts recover after heart attack - Oxford research

Researchers at the University of Oxford have identified a drug that could ultimately help improve heart function in people with diabetes who have heart attacks.

Largest ever global study of tuberculosis identifies genetic causes of drug resistance

Using cutting-edge genomic sequencing techniques, researchers at the University of Oxford have identified almost all the genomic variation that gives people resistance to 13 of the most common tuberculosis (TB) drug treatments.

AIMday in Women's Health - registration for academics now open

Are you an academic interested in finding out how your knowledge can be used to solve industry challenges? Would you like to widen your network? Meet potential collaborators / future employees? Gain insights into relevant funding schemes? If you answer YES to any of the above, now is the time to register for the AIMday in Women's Health.

Researchers set out steps to address mental health effects of the pandemic on young people

Researchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.

Anti-cancer drug derived from fungus shows promise in clinical trials

A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.